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ABSTRACT
CHARACTERIZING THE LIR DOMAIN OF ABIN1 AND IDENTIFYING ITS ROLE
AS A REGULATOR OF MITOPHAGY
ANDREW RHINER
2022
A20 Inhibitor of NF-κB (ABIN1/TNIP1) is a known regulator of TNFα signaling
induced cell death and inflammation. The regulatory activity has been attributed to
ABIN1’s recruitment of the ubiquitin editing enzyme TNF-α-induced protein 3
(TNFAIP3/A20) to Receptor-interacting serine/threonine-protein kinase 1 (RIPK1). The
regulation of RIPK1 by ABIN1 and A20 relies on a third player, linear ubiquitin chain
assembly complex (LUBAC), which is involved in the recruitment of ABIN1 to RIPK1.
Loss of LUBAC or ABIN1 is embryonic lethal, but loss of A20 is not embryonic lethal.
The embryonic lethality due to loss of ABIN1, paired with the lack of lethality with loss of
A20, provides evidence that ABIN1 plays a role in cellular regulation beyond its role in
recruiting A20 for RIPK1 regulation. We established that ABIN1 binds LC3 and is
degraded in an autophagy-dependent manner. We also found that ABIN1 is a binding
partner of mitochondria and plays a role in general housekeeping of mitochondria.
ABIN1’s regulation of mitophagy is an effect of its regulation of AMP-activated protein
kinase (AMPK) phosphorylation, an upstream regulator of mitophagy. Loss of ABIN1 and
its disruption of mitophagy appears to influence the release of mitochondrial DNA
(mtDNA) from the mitochondria. The presence of mtDNA in the cytosol presents a
potential explanation for Lupus in ABIN1 mutant patients.
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Chapter 1: Introduction
Cells exist within an ever-changing environment where they must constantly adapt
themselves at the molecular level to respond to changes. The core of maintaining cellular
homeostasis is the balancing of anabolic and catabolic processes within the cell to adapt to
changing environmental conditions and cell damaging events. Many of these processes are
regulated by post translational modifications such as phosphorylation, ubiquitination,
glycosylation, and lipidation[1-3]. One pathway responsible for regulating the balance of
anabolic and catabolic activity is autophagy, a process that allows the cell to break down
unwanted proteins and organelles and recycle them for further use. Macroautophagy,
hereafter referred to as autophagy, involves the trafficking of large proteins, protein
complexes, organelles, and membranes to double membrane vesicles, called
autophagosomes, that will terminally fuse with lysosomes and degrade their contents.
Autophagy is a tightly regulated process that requires precise signals to begin.
Initiation of autophagy is in large part controlled by the balancing of AMPK and
Mammalian Target of Rapamycin (mTOR) signaling[4]. AMPK and mTOR are both
responsible for the phosphorylation of Unc-51-like kinase 1 (ULK1)(Autophagy related
protein 1(ATG1) in yeast) but their separate phosphorylation sites have opposing effects.
AMPK phosphorylates ULK1 at Ser317 and Ser777, inducing its activation and therein
promoting autophagy. mTOR phosphorylates Ser757, which prevents binding of AMPK
and ULK1, in turn preventing the initiation of autophagy. These competing
phosphorylation signals allow for the balancing autophagy activity based on nutrient
availability.
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Autophagosome formation

Figure 1.1 Schematic of autophagosome formation
Schematic of the three steps of autophagosome formation. Initiation begins with the phosphorylation of
ULK1 and its subsequent phosphorylation of the members of its complex, ATG13, FIP200, and ATG101.
Nucleation relies on the PI3K kinase Vps34 sequestering phospholipids from existing membranes. The third
step, elongation, continues the nucleation and studs the exterior and interior of the forming phagophore with
ATG proteins.

The formation of autophagosomes has three steps: initiation, nucleation, and
elongation (Figure 1.1)[5]. Initiation begins with the activation of ULK1 by
phosphorylation of Ser317 and Ser777, which only become available when mTOR is
inhibited[6]. When nutrients are abundant and growth signaling is present mTOR is active
and ULK1 is inhibited. Once nutrients become sparse mTOR becomes inactivated and
allows AMPK to access ULK1 and phosphorylate it. ULK1 forms a complex with FAK
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family kinase-interacting protein of 200 kDa (FIP200), ATG13 and ATG101. The ULK1
complex is responsible for the initiation of recruitment of ATG proteins for sequestering
membranes[7].

The second step of autophagosome formation, nucleation, relies on Vacuolar
Protein-Sorting Protein 34 (Vps34), a membrane trafficking protein and part of a class III
phosphatidylinositol 3-kinase complex (PI3K) along with Vps15, Beclin 1 and ATG 14
(Figure 1.1)[8]. The PI3K complex acts to form membranes utilizing lipid bilayers of the
endoplasmic reticulum (ER), Golgi, mitochondria, recycled vesicles and plasma
membrane[9, 10]. From these sources the forming phagophore grows out and forms a
double membrane a characteristic that is distinct to autophagosomes. Another key area of
autophagosome formation is the contact points between mitochondria and ER, which often
forms the autophagosomes that will ultimately be responsible for engulfing and consuming
the mitochondria[11]. In the PI3K complex Vps34 is responsible for generating
phosphatidylinositol, while Beclin 1 regulates the recruitment of cofactors. Beclin 1 has
been shown to regulate the formation of varying autophagosomes based on which proteins
it recruits into the complex[12].
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Figure 1.2 Schematic of LC3 maturation
Schematic of LC3 maturation. ProLC3 is cleaved by ATG4, LC3 is then lipidated by ATG3 which attaches
a phosphatidylethanolamine. Lipidated LC3 is then studded into the interior of a phagophore.

The third step to autophagosome formation is elongation, which involves the
simultaneous elongation and nucleation of the phagophore along with two ubiquitin-like
protein conjugation systems (Figure 1.1). The first of these involves the formation of a
complex with ATG5, ATG12, ATG16[13]. ATG5 is first covalently attached to ATG10
by ATG7, before being transferred to ATG12 followed by the attachment of ATG16 to
ATG5 to form a mature complex that then forms heterodimers with other complexes. This
complex is responsible for assisting in the development of the maturing autophagosome.
Simultaneously, a second conjugation system is responsible for the generation of mature
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LC3, which will eventually stud the interior of the autophagosome and regulate recruitment
of substrates that need to be degraded (Figure 1.2)[14]. The ubiquitin-like system starts
with proLC3 being cleaved by the cysteine protease ATG4. Cleaved LC3 is then lipidated
by ATG7 and ATG3 to attach phosphatidylethanolamine (PE) which allows for the
embedding of the LC3 into the inner membrane of the expanding autophagosome. Once
the autophagosome has finished forming and is studded with LC3 it will either begin to
engulf what is around it, if formed around the substrate it is intended to degrade, or split,
from the membrane source and form an independent structure where it is then sequestered
to the area of the cell it is needed.
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Figure 1.3 Schematic of AMPK pathway
AMPK pathway detects changes in nutrient availability and activates catabolic pathways in response.
Decreases in metabolite availability, damage to mitochondria, ischemia or increases in Ca2+ levels cause
LKB1 or CAMKK2 to phosphorylate AMPK at Thr 172. AMPK subsequently phosphorylates ACC, ULK1,
and Raptor to inhibit anabolic pathways and initiate the autophagy-pathway.

AMPK activation
AMPK is the kinase responsible for phosphorylating ULK1 and triggering the
autophagy pathway in which the autophagosome is formed. AMPK is a trimeric protein
that acts as a nutrient sensor and becomes phosphorylated at Thr172 on AMPKα in

7

response to energy stress[15]. The activation of AMPK can be done by two different
kinases depending on the source of stress (Figure 1.3). Liver Kinase B1 (LKB1) acts as a
nutrient sensor by sensing changes in the ratio of AMP/ADP to ATP, and as the relative
ratio of AMP increases the three parts of AMPK will colocalize and LKB1 will be recruited
to them and phosphorylate AMPK[16]. The other kinase able to phosphorylate AMPK is
Calcium/Calmodulin Dependent Protein Kinase 2 (CAMKK2), a calcium ion sensor that
phosphorylates AMPK in response to fluxes in calcium levels, often triggered by hormones
binding to membrane receptors. The phosphorylation will cause AMPK to become active
and, in turn, phosphorylate three primary targets: ULK1—upregulating autophagy, ACC—
inhibiting fatty acid and cholesterol synthesis, and Raptor —inhibiting mTOR[17]. AMPK
upregulates a variety of catabolic pathways while simultaneously inhibiting anabolic
pathways, making it a key regulator of cellular homeostasis.
mTOR pathway
In contrast to AMPK, mTOR works to inhibit catabolic processes and promote
anabolic processes. mTOR phosphorylates ULK1 at Ser757, preventing its interaction with
AMPK and as an effect of that downregulating autophagy. Simultaneously mTOR
phosphorylates S6K-1 and 4EBP-1 to upregulate protein synthesis[18]. These two kinases
work to balance the rate of autophagy within a cell and provide negative feedback loops
for one another so that the upregulation of anabolic processes will downregulate catabolic
processes and vice versa.
Structure of Autophagy Receptors
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Autophagy is generally a selective process that is regulated by cargo receptors
containing the LC3 interacting region (LIR) motif F/W/V-X-X-L/I/V. These cargo
receptors act as scaffolding proteins to substrates that need to be degraded in
autophagosomes[19]. These LIR containing proteins are referred to as autophagy receptors
and are typically selective in their autophagy pathway, with many only acting in one of the
selective autophagy pathways, and only a few being fairly promiscuous. The most well
studied, and arguably the most promiscuous, is the autophagy receptor Sequestome 1
(p62/SQSTM1)[20]. p62 was first identified as a protein that shuttles protein aggregates to
the autophagosomes to be degraded. Since then its role has grown and it has been found to
act in almost all autophagy subtypes. While all autophagy receptors possess the capacity
to bind LC3, another capability found among most selective autophagy receptors is the
capacity to bind Lys-63 ubiquitin chains[21]. To date, approximately half of all known
selective autophagy receptors have a ubiquitin binding region that binds Lys-63 ubiquitin
chains, Met1 ubiquitin chains or both.

Figure 1.4 Schematic of ubiquitination
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There are three steps to the conjugation of ubiquitin to a substrate. The first step is activation which is the
attachment of ubiquitin to a ubiquitin activating enzyme, E1. The second step is conjugation where the E1
transfers the ubiquitin to a ubiquitin-conjugating enzyme, E2. The third step is ligation during which the E2
either transfers the ubiquitin to a ubiquitin ligase, E3, which will then attach the ubiquitin to a substrate or
the E2 will attach the ubiquitin to the substrate in coordination with the E3. After the initial ubiquitin is
attached to the substrate subsequent ubiquitin can attach to the already present ubiquitin to generate ubiquitin
chains.

Ubiquitination of autophagy substrates
Post translational modifications are mechanisms cells utilize for a variety of
purposes within a cell to active or inhibit, such as ULK1, as mentioned previously, alter
structure, such as the lipidation of LC3 which allows it to become embedded in the
autophagosome, and can also be used to determine the fate of a substrate. Ubiquitination,
the attachment of an 8 kDa protein called ubiquitin, can mark substrates within the cell for
degradation. Ubiquitination starts with the ATP dependent attachment of a ubiquitin to an
E1 ubiquitin-activating enzyme, ubiquitin is then transferred to an E2 ubiquitinconjugating enzyme and finally the ubiquitin is transferred to its target substrate via the
coordination of an E2 and E3 ubiquitin ligase (Figure 1.4)[22]. E3 ubiquitin ligases have a
great deal of specificity for what they will target as well as for the way in which they
conjugate the ubiquitin chains. Ubiquitin can be conjugated as mono-ubiquitin, multi
mono-ubiquitin, homotypic chains, or heterotypic chains[23]. The description of the chain
is based on the area of linkage, namely which lysine on the previous ubiquitin the Cterminal glycine of the subsequent ubiquitin is attached to. The currently known ubiquitin
chain types are Lys-11, Lys-27, Lys-29, Lys-33, Lys-48, and Lys-63 which each attach to
a lysine and then Met-1, which attaches the C-terminal glycine of the subsequent ubiquitin
to the N-terminal methionine of the previous ubiquitin. For the degradatory pathway, Lys48 are associated with proteasomal degradation of the ubiquitinated substrate[24]. Lys-63
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and Met-1 ubiquitin chains have both been found to function in the positive regulation of
autophagy, but both ubiquitin chain types also possess roles in pathways outside of
autophagy[25].
Selective Autophagy Subtypes
For selective autophagy there are a few specific classes of autophagy that involve
the degradation of a particular organelle or pathogen. These include mitophagy
(autophagy-dependent degradation of mitochondria), xenophagy (autophagy dependent
degradation of intracellular bacteria), ERophagy (autophagy-dependent degradation of
endoplasmic reticulum), and virophagy (autophagy-dependent degradation of viral
capsids)[26-29]. Each of these selective autophagy subtypes have unique autophagy
receptors associated with them, with some having overlapping promiscuous receptors.
However, they all have the same outcome, degradation of cargo via lysosomes.
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Figure 1.5 Schematic of mitophagy
When mitochondria become damaged and can no longer maintain a proton gradient, they become
depolarized. Depolarization in turn causes the ratio of AMP:ATP to increase, since the mitochondria can now
not generate sufficient ATP, inducing AMPK phosphorylation and the subsequent activation of the
mitophagy pathway. Another biproduct of depolarizing mitochondria is increased permeability of the
membranes which can allow mtDNA to escape from the mitochondria and activate the cGAS-STING
pathway.

Mitophagy
The primary role of mitochondria in cells is generation of ATP, the primary energy
source for cellular processes. Disruption to the production of ATP causes disruption in
most metabolic processes of the cell, therefore maintenance of these organelles is vital. The
production of energy exposes mitochondria to damaging molecules, specifically reactive
oxygen species (a byproduct of energy production) that can induce damage to
mitochondrial DNA as well as the proteins necessary for the generation of the ATP (Figure
1.5)[30, 31]. Mitochondria have developed intricate mechanisms to regulate their
mitochondrial network, consisting of opposing forces of regular turnover and specific halflives for each component coupled with mitochondrial biogenesis which adds new proteins
and lipids to existing mitochondria. However, when it is necessary for entire mitochondria
to be recycled due to damage or a decreased need for energy cells utilized the selective
autophagy pathway, mitophagy.
Because of how vital mitophagy is, cells have developed a level of redundancy so
if one set of proteins, such as mitophagy receptors, fails others can take over and still
accomplish turnover of mitochondria. One of the most widely studied molecular pathways
in mitophagy is the PTEN Induced Kinase 1 (PINK1)/Parkin pathway[32, 33]. When
mitochondria are healthy, PINK1 has no place to bind on the outer membrane of the
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mitochondria and is thus quickly degraded by the proteasome upon being shuttled out of
the mitochondria. Upon mitochondrial damage when translocase of the outer membrane
(TOM) proteins become damaged PINK1 can bind to the outside of mitochondria and
becomes stabilized. Stabilization on the exterior of the mitochondria allows PINK1 to
phosphorylate Parkin, an E3 ubiquitin ligase located on the exterior of the mitochondria,
activating it and causing Parking to ubiquitinate substrates on the exterior of the
mitochondria. The generation of Lys-63 chains signals to the cell to begin recruiting
autophagy associated proteins to the mitochondria and subsequently induces mitophagy.
When PINK1 or Parkin become disrupted the recruitment of mitophagy associated proteins
becomes disrupted and cells struggle to maintain normal mitochondrial levels and in turn
regulate their AMP:ATP levels. Interestingly, loss of a single mitophagy receptor is not
detrimental to cells; it is only detrimental when two or more mitophagy receptors are lost
that a significant difference in cells’ ability to regulate mitochondrial levels occurs[26].
Xenophagy
Xenophagy is another selective autophagy receptor mediated form of degradation,
but instead of degrading a cellular component it is responsible for the degradation of
intracellular bacteria.[34] The current understanding is that when bacteria invade a cell,
the cell marks them for degradation by the autophagosome. One of the ways xenophagy is
understood to occur is by recruiting E3 ubiquitin ligases to the exterior of the cells, which
will then generate ubiquitin chains on the LPS for autophagy receptors to bind.[35]. Ring
Finger Protein 213 (RNF213) has been identified as the E3 ubiquitin ligase responsible for
the initiation of the ubiquitination of the pathogenic bacteria Salmonella and Toxoplasma
gondii[35]. Salmonella has been the most widely studied of the invasive pathogens due to
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its ease of study. Analysis of Salmonella after the bacteria has invaded the cell revealed
Salmonella gets Lys-63 and Met-1 ubiquitinated, which in turns drives it towards
autophagosomal degradation[36]. It was originally thought that LUBAC, the only E3
ubiquitin ligase capable of generating Met-1 ubiquitin chains, was being directly recruited
to the exterior of the pathogen. Recent work, however, has shown that the recruitment of
LUBAC relies on the initial activity of RNF213, indicating that the cascade of
ubiquitination on the exterior of invasive bacteria is dependent entirely on RNF213[37].
Another key player in xenophagy is the V-ATPase-Atg16L1 relationship[38]. Upon
infection, Salmonella has been shown to become bound with V-ATPase, a proton pump
that induces acidification of the pathogen. V-ATPase is essential for the recruitment of
ATG16L1 to the bacteria, which then causes formation of the autophagosome around the
pathogen.
Overlap between Mitophagy and Xenophagy
While mitophagy and xenophagy are two distinct processes and pathways, among
the selective autophagy receptor subtypes they possess an interesting amount of overlap.
Both rely on the activity of TBK1 to phosphorylate some of their autophagy receptors to
increase binding activity, namely Optineurin (OPTN) in mitophagy and Calcium-binding
and coiled-coil domain-containing protein 2 (NDP52) in xenophagy[39]. Beyond this, they
have very similar pathways through which they act, as both rely on ubiquitination of the
substrate, binding of autophagy receptors to the ubiquitin and subsequent shuttling of these
autophagy receptors into the autophagosome. The overlaps between the selective
autophagy of bacteria and mitochondria suggests that these pathways may evolved
simultaneously, and that the specificity of the autophagy receptors is what sets them apart.
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cGAS-STING
The cGAMP synthase (cGAS)- Stimulator of Interferon Genes (STING) pathway
is an innate immune response that is activated upon sensing the presence of double stranded
DNA (dsDNA)[40]. The sources of dsDNA can vary, but the most canonical activation is
the infection of dsDNA viruses[41]. Upon dsDNA entering the cytosol, it activates the
pathogen associated molecular pattern (PAMP) cGAS, which, in turn, activates the second
messenger Cyclic guanosine monophosphate-adenosine monophosphate (cGAMP).
STING then binds to cGAMP, which causes the complex to be transferred from the ER to
the Golgi. The translocation and activation of cGAMP causes the downstream activation
of Tank Binding Kinase 1 (TBK1), Interferon Regulatory Factor 3 (IRF3), and
inflammatory cytokine production. The cGAS-STING pathway besides responding to viral
dsDNA, will also recognize nuclear DNA, mtDNA, and bacterial DNA when present in
the cytosol[42]. When mitophagy or xenophagy become disrupted, there is a causal
opportunity for STING activation.
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Figure 1.6
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Upon TNF binding to TNFR1 Complex I consisting of TRADD, TRAF2/5, cIAP1/2, and RIPK1 is recruited.
Subsequently the ubiquitin ligase LUBAC, which generates Met-1 ubiquitin chains, is recruited to Complex
I. Generation of Met-1 ubiquitin chains on RIPK1 in turn recruits ABIN1 which provides a scaffolding for
the ubiquitin editing enzyme A20. The ubiquitin modification by A20 prevents Complex II formation and
upregulates NF-κB activation of pro survival genes. When ABIN1, A20 or LUBAC are disrupted Complex
II forms, consisting of FADD, Caspase8, and RIPK1. Generation of Complex II leads to apoptosis by
inducing Caspase7 and Caspase3 activation, or necroptosis when Caspase8 is inhibited and Caspase3
complexes with FADD and RIPK1 and recruits MLKL.

ABIN1: A negative regulator of NF-kB
ABIN1 is a binding partner of A20 that acts as a scaffolding protein to recruit A20
to the Tumor Necrosis Factor pathway and down regulate cell death[43]. A20 is a ubiquitin
editing enzyme that prevents apoptosis and necrosis in response to TNF induced signaling.
Upon the binding of TNF to TNF Receptor (TNFR), Complex I is formed, consisting of
Tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD),
TNFR Association Factor (TRAF) 2/5, cellular inhibitor of apoptosis protein1/2(cIAP1/2),
LUBAC, and RIPK1[44]. RIPK1 in Complex I is then ubiquitinated with both Met-1
ubiquitin and Lys-63 ubiquitin by LUBAC and cIAP1/2 (Figure 1.6). A20 prevents the
removal of Met-1 ubiquitin of RIPK1 by Ubiquitin carboxyl-terminal hydrolase (CYLD)
and replacement of it with Lys-63 ubiquitin, preventing the formation of Complex II. When
complex II is formed, consisting of RIPK1, FADD, and Caspase8, which can either induce
apoptosis in a Caspase3 and Caspase7 dependent manner or necrosis by recruiting mixed
lineage kinase domain-like (MLKL) to Complex II. In the absence of A20, Met-1 ubiquitin
is removed from RIPK1 at an increased rate and Lys-63 ubiquitin can attach. Loss of the
proteins responsible for modulating RIPK1 ubiquitination sensitizes cells to TNF induced
cell death.

18

The role of ABIN1 is the recruitment of A20 to Complex I, when ABIN1 is absent
cells become sensitized to cell death in a TNF dependent manner as if A20 was absent[45].
ABIN1 is recruited to the Met-1 ubiquitin chains on LUBAC or RIPK1 and then acting as
a scaffolding protein for A20[46]. Loss of ABIN1’s capacity to bind Met-1 ubiquitin causes
it to become sensitized to TNF. The currently established role of ABIN1 is as a regulator
of TNF dependent inflammation, dependent on its ability to bind Met-1 ubiquitin.

ABIN1 role in disease
The diseases most associated with ABIN1 are Lupus, Psoriasis, and autoimmune
disorders[47-49]. The primary effect of ABIN1 mutations has been found to be related to
changes in regulation of inflammatory signaling within cells. Lupus is characterized by B
cells generating auto antibodies and an uncontrolled inflammatory response. Unregulated
NF- kB activation occurs when TNF signaling is no longer being downregulated by ABIN1
upstream in the pathway. In Psoriasis it has been found that the TNF signaling is
unregulated along with Interleukin-17, a pro inflammatory cytokine. Another factor is that
normally ABIN1 recruits A20 to IKK for deubiquitinating activity[50]. In Psoriasis,
instead of autoimmune signaling originating in B cells it instead comes from deregulated
keratinocytes. Autoimmune disorders related to ABIN1 have been found to involve the two
previous pathways as well as dysregulation of Toll Like Receptor(TLR)-Myeloid
differentiation primary response 88 (MyD88)[49]. ABIN1 has been found to directly bind
Interleukin-1 receptor-associated kinase 1 (IRAK1), dependent on its UBAN domain, and
downregulate inflammatory signaling. Loss of regulation in these inflammatory pathways
causes CD40 signaling activation and subsequent B cell activation with upregulated IκB
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kinase (IKK) activation and c-Jun N-terminal kinase (JNK) signaling. While some of the
exact signaling has been elucidated, there appear to be other increased inflammation
unexplained by the current models.
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Chapter 2: Results
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Figure 2.1
ABIN1 possesses the domains of an autophagy receptor and binds LC3
A) Evolutionarily conserved LIR domain of ABIN1 LIR motif. B) Schematic of ABIN1 mutations
made to LIR domains to disrupt LC3 binding. C) GST pulldown using recombinant Ubiquitin, LC3a
and LC3b with eluted MBP ABIN1. D) Surface Plasma Resonance using ABIN1 and bound LC3.
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While searching for novel autophagy receptors ABIN1 was noted as a putative
autophagy receptor due to its apparent LIR motifs discovered via bioinformatics using
HHpred. Mutants were then generated by introducing two separate point mutations at the
first LIR 1 F84A L87A, two separate point mutations at the second LIR 2 F137A V140A,
or both LIRs mutated (LIR 1 LIR 2). A pull-down testing ABIN1’s ability to bind LC3
dependent on these LIR domains was then performed, with 4xUbiquitin, which is generated
using a plasmid with four ubiquitin expressed one after another so they will be expressed
C-terminal Glycine to N-terminal Methionine the same way Met-1 ubiquitin are
conjugated, which can used as a positive control as ABIN1 is known to bind linear ubiquitin
chains. This pull-down showed that ABIN1 can directly bind both LC3a and LC3b, with
increased binding to LC3a and showed that the binding is dependent on the LIR domains.
While loss of only one LIR domain mildly disrupts their binding, mutations in both LIR
domains completely disrupt ABIN1 LC3 interactions. We confirmed the binding affinity
by performing surface plasmon resonance (SPR) using bound LC3 and flowing ABIN1
over that. From the data obtained from SPR we determined that ABIN1 has a dissociation
constant (KD) of 19.3±1.3µM.
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Figure 2.2
ABIN1 is degraded by the lysosomes upon inducing autophagy
Cells were lysed in RIPA buffer and run on SDS page for western blot analysis (representative of three
individual experiments) A) HeLa cells were grown in EBSS for the indicated period. B) HeLa cells were
grown in EBSS supplemented with 500nM Bafilomycin A1 for indicated period. C) HeLa cells stably
expressing inducible recombinant ABIN tagged Strep-Strep-HA treated with Doxycycline for 16 hours and
then cultured in EBSS for indicated time. D) HeLa cells stably expressing inducible recombinant ABIN
tagged Strep-Strep-HA treated with Doxycycline for 16 hours and then treated with fresh media alone or
supplemented with 500nM Bafilomycin A1, 100uM Bortezomib or both.

After establishing that ABIN1 can bind LC3 we looked at the effects of autophagy
on endogenous ABIN1 levels. To examine ABIN1’s response to autophagy induction we
cultured HeLa cells in EBSS, a non-supplemented starvation medium known to induce
autophagy due to nutrient deprivation and tracked the changes in ABIN1 levels over the
time period along with p62, a known autophagy receptor. We observe that ABIN1 levels
decrease upon autophagy induction that mirrors changes in p62. To confirm that EBSS was
inducing autophagy we then blocked lysosomal degradation using Bafilomycin A1. When
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HeLa cells were cultured in EBSS paired with Bafilomycin A1, to block lysosomal
acidification, ABIN1 levels increase in parallel with p62. To examine the effects of
mutating the LIR domain in ABIN1 levels in response to autophagy, we cloned WT ABIN1
and LIR1/2 ABIN1, hereafter referred to as ABIN1-WT and ABIN1-LIR, into
pcDNA5/FRT/TO tagged with C terminal Strep-Strep-HA. We then stably expressed
ABIN1-WT and ABIN1-LIR in HeLa TREX FRT cells. Expression of ABIN1-WT and
ABIN1-LIR in HeLa cells was induced with doxycycline (dox) overnight, the next day
media was replaced, and cells were cultured in EBSS for the indicated time. ABIN-WT
and ABIN1-LIR levers were both found to be decreasing over the time course. To better
understand the ways in which ABIN1 was being degraded, we utilized the Tet-Repressor
system to induce the expression of ABIN1-WT and ABIN1-LIR with dox and then
subsequently stopping the expression of ABIN1 by washing away the dox. As expression
of ABIN1 was turned off, we prevented lysosomal degradation by treating with
Bafilomycin A1, which prevent the acidification of lysosomes, prevented proteasomal
degradation by treating with Bortezomib, which blocks the proteasome binding pocket, or
treated with both drugs to prevent both forms of degradation. From this we determined that
ABIN1 was degraded in both the proteasome and the lysosomes, and that the LIR mutant
seemed to be resistant to it as it had no apparent difference between the bortezomib treated
and bafilomycin/bortezomib treated samples. These findings show ABIN1 levels are
decreasing upon autophagy induction and increasing upon inducing autophagy paired with
blocking lysosomal degradation. These results show that ABIN1 is degraded in an
autophagy-dependent manner and further support that ABIN1 is an autophagy receptor.
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Figure 2.3
Mutations to the LIR domain of ABIN1 cause it to become hyperphosphorylated
A) Recombinant ABIN1 WT, LIR or UBAN tagged with Strep-Strep-HA transiently transfected in 293T
cells. Immunoprecipitation with HA magnetic beads was done followed by treatment of the enriched protein
with phosphatase. Samples were analyzed by western blot (representative of two individual experiments).
Stable reconstituted ABIN1 cells lines untagged in ABIN1-/- MEFs (B) or Strep-Strep-HA tagged ABIN1 in
HeLa TREX Cells.

Upon expressing ABIN1 WT and mutant LIR we noticed that mutations in the LIR
domain caused ABIN1 to elicit a reduced electrophoretic mobility compared to ABIN1
WT. This reduced electrophoretic mobility is consistent during expression in HeLa, MEF,
U2OS, and 293T cells. We looked to examine what post-translational modification was
causing this and decided to examine the potential of phosphorylation. We expressed
ABIN1-S-S-HA in 293T cells and then immune-precipitating ABIN1 using HA magnetic
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beads and treating the enriched ABIN1 with phosphatase. This caused the ABIN1-WT,
ABIN1-LIR and ABIN1-UBAN, which possess mutation at D485N F486N, to have
increased electrophoretic mobility. This confirmed that ABIN1 is being phosphorylated
and that upon loss of its LIR motif, causing loss of ability to bind LC3, ABIN becomes
hyperphosphorylated.

Figure 2.4
ABIN1 colocalizes with the mitochondria, this increases upon mitochondrial
depolarization
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A) HeLa TREX cells stably expressing ABIN1-S-S-HA were grown on coverslips overnight in the presence
of 10ug/ml doxycycline. Cells were treated with 250nM MitoTracker Deep Red for 45 minutes before fixing
with 4% formaldehyde and then immunofluorescence was done using anti-HA and colocalization of HA and
MitoTracker was determined using Coloc 2 and Pearson Correlation was given, n>50. Fisher score was
determined using Microsoft Excel. B) Thermofisher mitochondrial isolation kit was used on WT MEFs.
Fractions were run on Bio Rad precast 4%-15% SDS page and analyzed by western blot (representative of
three individual experiments).

After confirming that ABIN1 is degraded in an autophagy-dependent manner, we
asked if ABIN1 co-localized with mitochondria. Towards this end, we examined ABIN1
in HeLa cells using Immunofluorescence (IF) by using MitoTracker to stain the
mitochondria and then fixing with formaldehyde and immunostaining with HA antibody
to detect HA-ABIN1. ABIN1 was found to colocalize with mitochondria and this
colocalization increases upon treating cells with CCCP, a potent mitochondrial depolarizer.
We further confirmed the interaction between ABIN1 and mitochondria by performing
mitochondrial isolation and found that ABIN1 was in the mitochondrial fraction. We used
tubulin as the control for the cytosolic fraction and TOM20 as the control for the
mitochondrial fraction.
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Figure 2.5
ABIN1 is degraded in a mitophagy specific manner dependent on its LIR domain
WT MEFs or MEFs reconstituted with LIR mutated ABIN1 were lysed in 1x Laemmli Buffer and run on Bio
Rad TGX precast gels 4%-15% for western blot analysis (representative of three independent experiments) .
A) MEFs treated with 10uM CCCP for the indicated period. B) MEFs were treated with 10uM CCCP and
200nM Bafilomycin A1 for the indicated period. C) ABIN1-/- MEFs were reconstituted with ABIN1-LIR and
treated with 10uM CCCP for the indicated period.

To investigate the potential of ABIN1 as a mitophagy receptor, we selectively
induced mitophagy using CCCP, a mitochondrial depolarizer, and examined changes in
ABIN1. To monitor for mitophagy activation, we assessed the phosphorylation status of
AMPK (pAMPK), which occurs during mitophagy induction due to increases in the ratio
of AMP/ADP:ATP, and for the PINK1 levels, which is stabilized upon mitochondrial
damage. We also assessed the levels of p62, which is not a primary mitophagy receptor but
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is degraded during general autophagy. As expected, p62 levels did not decrease under these
conditions, indicating that general autophagy wasn’t induced. Actin was used as a loading
control. In WT MEFs, ABIN1 levels decrease in as a result of mitochondrial
depolarization, while pAMPK and PINK1 levels increase, thus indicating that mitophagy
has been induced and suggesting that ABIN1 is degraded. In CCCP treated cells, p62 levels
remained stable, indicating that general autophagy was not induced. However, when cells
are treated with CCCP and Bafalomycin A1, ABIN1 levels increase despite the induction
of mitophagy, as indicated from increases in PINK1 and pAMPK. We then looked at
ABIN1 levels when ABIN1’s ability to bind to LC3 is disrupted by inducing mitophagy in
MEFs stably expressing ABIN1-LIR. Surprisingly, we found that ABIN1 levels increase
with the treatment of CCCP. This shows that mitophagy-dependent degradation of ABIN1
is dependent on the LIR domain. Interestingly, we also observe that phosphorylation of
AMPK appears to be decreased when the LIR domain of ABIN1 is mutated.
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Figure 2.6
Loss of ABIN1 disrupts mitophagy and mitochondrial maintenance
A) WT MEFs or ABIN1-/- MEFs were grown on Labtech dishes and incubated with LysoTracker Blue DND22 and MitoTracker Deep Red for 45 minutes and then imaged or for 30 minutes and then spiked with 10uM
CCCP for an additional hour. Colocalization was determined using Coloc 2 in FIJI n>50. Fisher value was
calculated using Microsoft excel. B) MEFs were grown on coverslips and then fixed with 4% formaldehyde
before staining with TOM20 antibody, dsDNA antibody, and DAPI. C) Number of cells with 2 or more
dsDNA puncta not overlapping with TOM20 was counted and graphed. D) ATP assay was used on MEFs
WT, ABIN1-/-, or reconstituted ABIN1 WT cells. Results were normalized to WT MEFs and analyzed by
Student’s t-test **p<0.01, n=8.

After establishing that ABIN1 colocalizes with the mitochondria, we examined if
loss of ABIN1 affected mitochondrial maintenance in MEFs derived from ABIN1-/- mouse
embryos. We examined if mitochondria would be sequestered to the autophagosomes at
the same rate in ABIN1-/- MEFs as it was in WT MEFs. We incubated cells with
MitoTracker and LysoTracker prior to damaging the mitochondria so that the organelles
would be fluorescent before they were trafficked. We found that in both WT and ABIN1-/cells untreated there was no colocalization of the mitochondria and lysosomes. Upon
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treating with CCCP for 1 hour we found that there was no significant difference in WT
MEFs compared to the ABIN1-/- MEFs, p>0.05. This showed that loss of ABIN1 had no
major effect on the sequestering of mitochondria to autophagosomes. Mutations to
ABIN1’s UBAN domain causes Lupus like symptoms in mice, and the underlying cause
is still unknown. Cytosolic mtDNA has separately been shown to cause Lupus like
symptoms. Based on this we examined WT and ABIN1-/- cells for the presence of mtDNA
in the cytosol, a phenomenon that does not usually occur in typical cells. We did this by
immunostaining with a TOM20 antibody in combination with dsDNA antibody and then
examining cells for the presence of dsDNA in the cytosol in places absent of accompanying
TOM20 signal. Because the dsDNA antibody also stains nuclear DNA, DAPI was used to
identify the nucleus and signal from the nucleus was not counted. For each cell type, 45
cells were scored for the presence of apparent mtDNA. We found that in ABIN1-/- cells
~50% of cells appeared to have dsDNA signal with no overlapping TOM20 signal while
only ~3% of WT cells had the same phenomenon. This indicates that there is mtDNA in
the cytosol of cells lacking ABIN1. We were also interested in assessing the abundance of
mitochondria in ABIN1-/- cells compared to WT. To determine if there appeared to be more
mitochondria in ABIN1-/- cells, ATP levels were quantified. We found that in cells lacking
ABIN1 there were significantly higher ATP levels compared to WT cells, and that
reconstituting WT ABIN1 in these cells reduced the ATP levels to those observed in WT
cells.
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Figure 2.7
Loss of ABIN1 inhibits AMPK phosphorylation upon mitochondrial depolarization
A) WT MEFs as well as ABIN1-/- MEFs (A), reconstituted ABIN1-WT MEFs (B) or reconstituted ABIN1LIR MEFs (C) were treated with CCCP for indicated time period and then analyzed by western blot
(representative of 3 independent experiments). D) The ratio of pAMPK:AMPK levels for the ABIN1-/-,
+ABIN1-WT, or +ABIN1-LIR MEFs was normalized to the WT MEFs for each time point and compared
using Student’s t-test *p<0.05, **p<0.01.

Initial work to establish that ABIN1 is degraded in a mitophagy-dependent manner,
a decrease in pAMPK was observed in ABIN1-/- cells expressing ABIN1-LIR following
mitochondrial depolarization. To determine the domains in ABIN1 that are required for
AMPK phosphorylation, we reconstituted ABIN1-/- cells with ABIN1-WT or ABIN1-LIR.
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While reconstituting ABIN1-/- cells with ABIN1-WT restored the AMPK phosphorylation
to levels found in WT MEFs, reconstituting cells with ABIN1-LIR mutants did not full
restore the AMPK phosphorylation, suggesting that ABIN1-autophagasome interaction is
required for AMPK phosphorylation upon mitochondrial depolarization.
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Chapter 3: Discussion
The precise lysosomal degradation of cargo in response to autophagy activation
requires autophagy adaptors and receptors. Of the UBAN domain containing proteins
identified thus far as autophagy receptors, only NEMO and ABIN1 remained to be
characterized as autophagy receptors. We found that ABIN1 binds directly to LC3 (Fig.
2.1 C,D) and is degraded in the lysosomes (Fig. 2.1 A,B) suggesting that it could function
as an autophagy receptor. To further investigate this possibility, we used bioinformatics to
identify putative LIR domains within ABIN1 that would facilitate a physical interaction
with LC3. Mutational ablation of these two LIR motifs resulted in the inability for ABIN1
to interact with LC3 (Fig. 2.2 C).
Mitochondria regulation is a key process for maintaining cellular homeostasis. We
provide evidence that cells lacking ABIN1 have a difference in their basal mitochondria
level (Fig. 2.6 D). We first establish that ABIN1 is recruited to the mitochondria and this
recruitment increases upon damage to the mitochondria (Fig. 2.4 A,B). After inducing
mitophagy, we found that ABIN1 is degraded in a mitophagy specific manner (Fig. 2.5
A,B) and ABIN1’s degradation is dependent on the LIR domains (Fig. 2.5 C). The changes
in basal mitochondrial level are however not a result of any changes to mitochondrial
fission or recruitment of mitochondria to autophagosomes (Fig. 2.6 A). Instead ABIN1
appears to be regulating mitophagy by regulating the phosphorylation of AMPK (Fig 2.7
A,B,D), dependent on ABIN1’s LIR domain (Fig. 2,7 C,D). This suggests that ABIN1 may
play a role in nutrient sensing of a cell.
Numerous western blot analysis indicates that ABIN1 displays a species with
reduced electrophoretic mobility, reminiscent of phosphorylation. Utilizing an in vitro
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phosphatase assay, we confirmed that ABIN1 is phosphorylated. Interestingly, we found
that mutations in the LIR domains causes a quantitative ABIN1 hyperphosphorylation (Fig
2.3 A). At this time, we have not identified the kinase responsible for phosphorylating
ABIN1 nor have we found the phosphatase responsible for dephosphorylating ABIN1. We
hypothesize that dephosphorylation of ABIN1 either occurs after ABIN1 is recruited to the
autophagosome or that the phosphorylation state of ABIN directs its localization within the
cell.
Many genes have been linked to Lupus but the exact cause of this disease to date is
still unknown. ABIN1 is one of the genes that has been correlated with Lupus in screenings
and has been consistently found to be downregulated in these patients. Another point of
interest is that mice with a mutation in the UBAN domain of ABIN1 have characteristic
Lupus like symptoms, but the underlying mechanism for this phenotype remains unknown.
Separately it has been found that mtDNA fragments in the cytoplasm cause lupus like
symptoms. For these reasons we decided to examine cells lacking ABIN1 for the presence
of mtDNA within the cytoplasm. Using immunofluorescence, we find that there is an
increase in the amount of mtDNA present in the cytosol of cells lacking ABIN1 (Fig. 2.6
B). This suggests that ABIN1 senses depolarized mitochondrial and either directly or
indirectly promotes mitophagy to maintain cellular homeostasis. Furthermore, in the
absence of ABIN1, the detection of depolarized mitochondria is delayed leading to cytosol
leakage of mtDNA which in turn elicits a strong inflammation response. Cytosolic mtDNA
might elicit an inflammatory response by activating the cGAS-STING. These
inflammatory pathways would in turn cause symptoms seen in Lupus patients as well as
autoimmune disorder patients.
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Materials and Methods
Antibodies and Reagents
Primary Antibodies were anti-ABIN1 (Proteintech 15104-1-AP 1:2000, Overnight 4°C),
anti-p62 (Cell Signaling 5114 1:1000, overnight 4°C), anti-Actin (Sigma-Aldrich
Mfcd00164531 1:5000, 1 hour room temperature), anti-HA.11(Biolegend 901513 1:5000,
1 hour room temperature), anti-AMPK(Cell Signaling 2532S 1:1000, overnight 4°C), antipAMPK(Cell Signaling 2535S 1:1000, overnight 4°C), anti-ACC(Cell signaling 3676T
1:1000, overnight 4°C), anti-pACC(11818T 1:1000, overnight 4°C), anti-PINK1(Novus
BC100-494), anti-TOM20(Cell Signaling 42406S 1:1000, overnight 4°C). Secondary
antibodies used were IRDye 800CW Goat anti-Rabbit (LI-COR 926-32211), IRDye
800CW Goat anti-Mouse (LI-COR 926-32210), IRDye 680RD Goat anti-Mouse (LI-COR
926-68070), Goat anti-Mouse IgG HRP (Invitrogen 31430), Goat anti-Rabbit IgG HRP
(Santa Cruz Biotechnology sc-2357), Western Blotting Luminol Reagent (Santa Cruz
Biotechnology sc-2048). Reagents used were Bafilomycin A1 (selleckchem s6494), CCCP
(Cayman Chemical Company 11038), Bortezomib (Sigma Aldrich 5.04314), EBSS
(HyClone SH30029.02), Doxycycline (Fisher BioReagents BP2653), Turbofect (Thermo
Scientific R0531), 0.05% Trypsin-EDTA (Gibco 25300-054), DMEM 1X (Corning 10013-CV), Penicillin-Streptomycin (HyClone SV30010), OPTI-MEM (Gibco 31985-062),
PBS (Gibco 14190-144), FBS (Premium Select S11550H), DTT (Research Products
International D11000), Protease Inhibitors (Roche 04693159001), PhosSTOP (Roche
04906845001), PMSF (Sigma Chemical Co. P-7626). Cell stains used were MitoTracker
Deep Red FM(Thermo Fisher M22426), LysoTracker Blue DND-22(Thermo Fisher
L7525).
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Cell Lines
HeLa cells and HEK-293T cells were purchased from AtCc. Wild type and ABIN1-/- mouse
embryonic fibroblasts were gifted to us by Dr. Averil Ma (UCSF). Cells were Cultured in
DMEM with 4.5 g/L glucose, L-glutamine, and sodium pyruvate supplemented with 10%
FBS and 100units/mL of Pen-Strep. Transfections were undertaken using 150μL of OPTIMEM, 1ug of plasmid and 5ul of TurboFect. 16-24 hours after cells transfection reagent
was applied media was changed. For flip-in cell lines, cells were transfected 900nG of
pOG44and 100ng of plasmid containing FRT sequence and 16-24 hours later drug
selection of choice was applied. For generation of retro virus HEK-293T cells were
transfected with 1μg of pCG-Gag Pol and 2 μg pCG-VSVG, 1 μg transfer gene, and 5 μL
TurboFect. Media was replaced on the plates 16-24 hours later and virus was then collected
48 hours later. Virus was applied to recipient cells for 16-24 hours, after which fresh media
was given along with selection drug. Plasmids used include pRetroX-Tight-Puro,
pcDNA5/FRT/TO-Hygro, and pIREShyg3.
Protein Purification
Recombinant MBP-ABIN1, GST, GST-LC3, and GST-4xUb was expressed in E.coli
Rosetta and grown overnight at 37°C in LB supplemented with 100μg/ml ampicillin.
Bacteria was then cultured until OD 0.600 before utilizing 0.5mM IPTG to induce
expression. Cultures were incubated overnight at 37°C then pelleted and washed with
1xPBS. Pellets were frozen at -80°C for 1 hour. Pellets were resuspended in 500mM NaCl
and PBS supplemented with 1mg/ml lysozymes, 1x Protease inhibitor, and 1mM DTT.

39

Pellets were sonicated until lysate was no longer viscous. Cellular debris were pelleted and
supernatant was incubated with Glutathione Sepharose beads for GST purification or
Amylose resin beads for MBP purification. Beads and supernatant were incubated for 3
hours at 4°C. Beads were washed 4x with 500mM NaCl and PBS before resuspending in
PBS. MBP-ABIN1 was eluted using 100mM Maltose.
Pull Downs
Pull downs were performed using purified GST, GST-4xUB, GST-LC3a, and GST-LC3b
bound to Glutathione beads along with eluted MBP-ABIN1 to determine binding. ABIN1
was incubated with GST, GST 4xUb, GST-LC3a, or GST-LC3b in 1x PBS for 1 hour.
Beads were spun down and washed 3x with PBS before running on SDS page and
analyzing by western blot.
Degradation Assay
HeLa cells stably expressing a Dox inducible ABIN1 were treated with 10nM Dox for 16
hours and then washed with PBS and given fresh media. When the fresh media was applied
cells were treated with bortezomib, Bafilomycin A1, or a combination of both, to determine
the modes of degradation of ABIN1.
Autophagy Assay
To examine the response of ABIN1 to general autophagy, wild type HeLa cells were
cultured in DMEM supplemented with 10% FBS and Pen-Strep until approximately 80%
confluent. Cells were then then washed with PBS and cultured in EBSS with or without
500nM Bafilomycin A1. Cells were harvested by scraping and then lysed in ice cold RIPA
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buffer supplemented with protease inhibitors and DTT. Extract was combined with
Laemmli sample buffer and run on an SDS page for Western blotting.
Mitophagy Assay
To examine the response of ABIN1 to mitophagy, WT and ABIN1-LIR MEFs were
cultured in DMEM supplemented with 10% FBS and Pen-Strep until approximately 80%
confluent. Cells were then washed with PBS then cultured in FBS free media for one hour.
Fresh media supplemented with 10% FBS and Pen-strep was then applied along with 10μM
CCCP alone or in combination with 200nM Bafilomycin A1. Cells were harvested by
scraping and then lysed in RIPA buffer supplemented with protease inhibitors and DTT.
Lysates were combined with 4x Laemmli sample buffer and run on an SDS page for
Western blotting.
ABIN1-HA IP and Dephosphorylation Assay
293T cells were transiently transfected using turbofect with ABIN1-Strep-Strep-HA WT,
LIR mutant, or UBAN mutant and grown for ~36 hours on 10cm dishes. Cells were
collected by trypsinization and washed with 1xPBS. Cells were then resuspended in 500mL
of 50mM Tris-HCl, 150mM NaCl, 0.1%NP-40, 10% glycerol, 1x Protease Inhibitor
cocktail, 1mM PMSF, and 10mM NEM. These tubes were then incubated on ice for 20
minutes, sonicated 5 seconds on 5 seconds off for 1 minute on ice, and then clarified by
centrifugation 15,000 rpm, 20 minutes, 4°C. Supernatants were transferred to fresh tubes
and 10μl was saved for input. The remaining supernatant was incubated with magnetic HA
beads (Thermo Scientific 88836) for 3 hours on a rotating wheel at 4°C. Afterwards beads
were washed with 500μL of the lysis buffer minus glycerol five times. Beads were then
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resuspended in 32μL of 20mM Tris-HCl pH 7.5, 150mM NaCl, 0.2% Triton X-100 and 1x
Protease Inhibitor cocktail. This was then split evenly into two fresh tubes. These fresh
tubes then received 2ul of 0.5M Tris-HCl pH 8, 1M NaCl, 100mM MgCl, and 10mM DTT.
One tube then received 2uL of FastAP Thermosensitive Alkaline Phosphatase (Thermo
Scientific EF0651) and the other tube received 2μL of resuspension buffer. The tubes were
all incubated at 37°C for 1 hour. Each tube was then given 5μL of Laemmli buffer before
running on a 10% agarose SDS page and subsequently analyzed by Western blot.
AMPK phosphorylation assay
Cells were cultured in DMEM supplemented with 10% FBS and Pen-Strep until ~80%
confluent. Cells were washed once with prewarmed serum free DMEM and then serum
starved for 1 hour in serum free DMEM. Media was changed to DMEM supplemented with
10% FBS and treated with 10uM CCCP for various time periods. Cells were collected by
scraping and then lysed in 25mM Tris-HCl pH 7.5, 150mM NaCl, 0.2% NP-40, 1x protease
inhibitor, 1x PhosSTOP and 1mM PMSF. Protein concentration was calculated using
Thermo Scientific Pierce BCA Protein Assay Kit (23227). Samples were combined with
Invitrogen 4x NuPAGE Sample buffer (NP0007) and 1mM DTT and incubated at 70° for
10 minutes. 20ug of each sample was run on a NuPAGE Bis-Tris 4-12% gel (NP0323BOX)
and subsequently transferred for western blot analysis.
Immunofluorescence/Fixed Cells
For fixed cell images HeLa or MEF cells were grown overnight on cover slips, in the
presence of 1ug/ml Dox for HeLa cells. The next day, dishes were washed with PBS and
then cells were fixed with 4% formaldehyde in 1x PBS for 15 minutes at room temperature.
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Cells were then washed 3x with 0.2% Triton X-100 in 1xPBS for 5 minutes each.
Coverslips were transferred to a humidity chamber and blocked with 2% BSA, 1xTBS,
0.1% Tween-20 for 1 hour. Blocking reagent was removed and primary antibody was
applied at 1:200 in blocking solution for 1 hour. Coverslips were then washed 3x with
1xTBS 0.1% Tween-20 for 5 minutes each. Secondary antibody was then applied at 1:200
in 5% BSA 1xTBS 0.1% Tween-20 for 1 hour. Coverslips were then washed 3x with
1xTBS 0.1% Tween 20 with the 3rd and final wash being supplemented with .1μg/ml DAPI.
Coverslips were then mounted to a slide using mowiol and allowed to dry overnight before
imaging.
Immunofluorescence/Live Cell imaging
For live cell imaging, MEFs were seeded onto glass bottom LabTek dishes with a
microwell. For live cell imaging of mitochondria, cells were given fresh media prior to
treating with 250nM Mitotracker Deep Red FM in prewarmed media for 45 minutes. For
live cell imaging of lysosomes, cells were given fresh media prior to treating with 75nM
Lysotracker Blue DND-22 for 1 hour. For examining colocalization of mitochondria and
lysosomes, MEFS were treated with both Mitotracker and Lysotracker for 30 minutes
before CCCP was added to the cells for 1 hour. Prior to imaging Mitotracker or Lysotracker
were washed off with 1xPBS and cells were given CO2 independent media supplemented
with 10% FBS.
Statistical Analysis
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Western blots were analyzed after incubation with antibodies using a LI-COR Odyssey XF
and intensity of bands was quantified using Empiria Studio 2.3. Colocalization was
calculated using the Coloc 2 plugin in Fiji and Pearson Correlation coefficient was used.
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